Analysts expect Silence Therapeutics plc to report revenue of 408,778.05 for 2026, against a range of 376,561.84 to 440,994.26. The most recent reported year, 2025, came in at 559,000.00, a 92.5% miss against the 7.49 M consensus.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 16.34 M | 21.06 M | 32.47 M | 43.26 M | 559,000.00 | - | - | ||
| High Estimate | 23.64 M | 30.72 M | 38.85 M | 26.79 M | 7.98 M | 440,994.26 | 1.42 M | ||
| Low Estimate | 20.03 M | 28.72 M | 35.88 M | 24.79 M | 7.01 M | 376,561.84 | 1.16 M | ||
| Consensus Estimate | 21.83 M | 29.72 M | 37.37 M | 25.79 M | 7.49 M | 408,778.05 | 1.29 M |
Analysts expect Silence Therapeutics plc to report earnings per share of -0.51 for 2026, against a range of -0.54 to -0.48. The most recent reported year, 2025, came in at -0.63, a 27.6% beat against the -0.87 consensus.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.58 | -0.50 | -0.50 | -0.33 | -0.63 | - | - | ||
| High Estimate | -1.11 | -0.39 | -0.40 | -0.64 | -0.80 | -0.48 | -0.57 | ||
| Low Estimate | -1.27 | -0.45 | -0.44 | -0.76 | -0.94 | -0.54 | -0.65 | ||
| Consensus Estimate | -1.19 | -0.42 | -0.42 | -0.70 | -0.87 | -0.51 | -0.61 |
Pull Wall Street consensus for Silence Therapeutics plc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=SLN&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "SLN", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=SLN&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();